中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
10期
192-193
,共2页
酒精相关性胃炎%替普瑞酮%治疗%疗效分析
酒精相關性胃炎%替普瑞酮%治療%療效分析
주정상관성위염%체보서동%치료%료효분석
Ethanol-induced chronic gastritis%Teprenone%Treatment%Curative effect analysis
目的：分析替普瑞酮治疗酒精相关性胃炎92例疗效。方法选取在我院接受治疗的酒精相关性胃炎患者92例，按病症情况将患者进行划分成A、B、C三组，A、B两组患者以替普瑞酮进行治疗，C组患者以硫糖铝片进行治疗。结果 A组患者治疗总有效率为84.3%、B组患者治疗总有效率为86.7%、C组患者的治疗总有效率为70%。A、B两组患者的治疗总有效率高于C组患者，而A、B两组患者在治疗总有效率上无显著差异。结论替普瑞酮治疗酒精相关性胃炎临床效果显著，安全性较高。
目的：分析替普瑞酮治療酒精相關性胃炎92例療效。方法選取在我院接受治療的酒精相關性胃炎患者92例，按病癥情況將患者進行劃分成A、B、C三組，A、B兩組患者以替普瑞酮進行治療，C組患者以硫糖鋁片進行治療。結果 A組患者治療總有效率為84.3%、B組患者治療總有效率為86.7%、C組患者的治療總有效率為70%。A、B兩組患者的治療總有效率高于C組患者，而A、B兩組患者在治療總有效率上無顯著差異。結論替普瑞酮治療酒精相關性胃炎臨床效果顯著，安全性較高。
목적：분석체보서동치료주정상관성위염92례료효。방법선취재아원접수치료적주정상관성위염환자92례，안병증정황장환자진행화분성A、B、C삼조，A、B량조환자이체보서동진행치료，C조환자이류당려편진행치료。결과 A조환자치료총유효솔위84.3%、B조환자치료총유효솔위86.7%、C조환자적치료총유효솔위70%。A、B량조환자적치료총유효솔고우C조환자，이A、B량조환자재치료총유효솔상무현저차이。결론체보서동치료주정상관성위염림상효과현저，안전성교고。
Objective To analyze the curative effect of teprenone on 92 patients with ethanol-induced gastritis. Methods 92 patients with ethanol-induced gastritis in our hospital were selected,and al the patients were divided into A,B,C three groups according to the state of diseases. The patients of A and B groups were treated with teprenone,and patients in group C were treated with sucralfate tablets. Results The total effective rate of group A was 84.3%,group B was 86.7%,and group C was 70%. The total effective rate of group A and B were better than that in group C,while there was no significant difference of total effective rate between group A and B. Conclusion The curative effect of teprenone on 92 patients with ethanol-induced gastritis is significant,the safety is higher.
